← All companies

REGN

Regeneron Pharmaceuticals, Inc.

REGN Nasdaq Pharmaceutical Preparations EDGAR ↗

$759.24

-3.39 -0.44%

Key statistics

from XBRL data in SEC filings

Market cap

$80.5B

Revenue (TTM)

$15.5B

Net income (TTM)

$4.33B

EPS (TTM)

$40.38

P/E ratio

18.8

Dividend yield

0.48%

Free cash flow

$4.08B

Cash

$2.46B

Total assets

$41.7B

Gross margin

—

52-week range

$541.00 – $821.11

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release) Jul 30, 2026 8-K Results of operations (earnings release) Jul 6, 2026 8-K Shareholder vote results Jun 17, 2026 10-Q Quarter ended 2026-03-31 Apr 29, 2026 8-K Results of operations (earnings release) Apr 29, 2026 8-K Results of operations (earnings release) Apr 8, 2026 10-K Fiscal year ended 2025-12-31 Feb 4, 2026 8-K Results of operations (earnings release) Jan 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Oct 28, 2025 8-K Results of operations (earnings release) Oct 28, 2025 8-K Results of operations (earnings release) Oct 6, 2025 10-Q Quarter ended 2025-06-30 Aug 1, 2025 8-K Results of operations (earnings release) Aug 1, 2025 8-K Shareholder vote results Jun 18, 2025 10-Q Quarter ended 2025-03-31 Apr 29, 2025 8-K Results of operations (earnings release) Apr 29, 2025 10-K Fiscal year ended 2024-12-31 Feb 5, 2025 8-K Results of operations (earnings release); Other events Feb 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release) Oct 31, 2024 8-K Results of operations (earnings release) Oct 7, 2024 10-Q Quarter ended 2024-06-30 Aug 1, 2024 8-K Results of operations (earnings release) Aug 1, 2024 8-K Results of operations (earnings release) Jul 8, 2024 8-K Shareholder vote results Jun 20, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release) May 2, 2024 10-K Fiscal year ended 2023-12-31 Feb 5, 2024 8-K Results of operations (earnings release) Feb 2, 2024 8-K Director or officer change Jan 31, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release) Nov 2, 2023 8-K Results of operations (earnings release) Oct 5, 2023 8-K/A Shareholder vote results Sep 8, 2023 8-K Director or officer change Sep 8, 2023 10-Q Quarter ended 2023-06-30 Aug 3, 2023